Drug development for the irritable bowel syndrome: current challenges and future perspectives
about
The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapyPalmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatmentsCurcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouseDistribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human ColonA systems-level "misunderstanding": the plasma metabolome in Huntington's diseaseDepolarizing Effects of Daikenchuto on Interstitial Cells of Cajal from Mouse Small Intestine.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Ex vivo study of human visceral nociceptors.Novel insights which may translate into treatments for irritable bowel syndrome.
P2860
Q33468382-C7A85163-35FF-4F21-85B6-EE8F36643732Q33958808-D7BB8479-3C11-45C5-A250-4E97EDD9C7CAQ34571380-44280BB9-A5D6-437A-8F2A-F8EAB6B9BDDFQ34660338-07DEACCD-43BF-4A0B-B41F-4CCD354923B1Q35049360-835F4780-D5E2-4220-80A7-9517DBEFFAF2Q35834548-FA568534-C0F5-4A8C-B502-0F4D73CF37D3Q35935105-9D8715EA-4FBD-42ED-B247-842DD8C3A853Q37640792-807203F2-B99A-44C4-8F24-AEFCF7CAB467Q38175457-0178D625-FD9D-461C-9B1E-7B653BF63D55Q38818922-1ED040B4-865C-4E09-AAEE-91FA9C13588EQ42150592-92D063DA-94A5-4E6D-8ACD-88C4AE2C10FA
P2860
Drug development for the irritable bowel syndrome: current challenges and future perspectives
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Drug development for the irrit ...... lenges and future perspectives
@ast
Drug development for the irrit ...... lenges and future perspectives
@en
type
label
Drug development for the irrit ...... lenges and future perspectives
@ast
Drug development for the irrit ...... lenges and future perspectives
@en
prefLabel
Drug development for the irrit ...... lenges and future perspectives
@ast
Drug development for the irrit ...... lenges and future perspectives
@en
P2860
P356
P1476
Drug development for the irrit ...... lenges and future perspectives
@en
P2860
P356
10.3389/FPHAR.2013.00007
P577
2013-02-01T00:00:00Z